From http://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
6,880 Disclosures Found for Payments in Virginia
Jump to: Important notes about this list.
Show only payments over $250
| Name / Payee | City | Company | Year | Category | Amount |
|---|---|---|---|---|---|
| VIRGINIA HEART | Falls Church | AstraZeneca | 2012 | Research | $18,492 |
| VIRGINIA HEART CARDIOVASCULAR GROUP | Fairfax | AstraZeneca | 2012 | Research | $17,870 |
| CARDIOLOGY CONSULTANTS OF DANVILLE INC. | Danville | AstraZeneca | 2012 | Research | $14,243 |
| CARDIOLOGY RESEARCH ACCOUNT CENTER | Lynchburg | AstraZeneca | 2012 | Research | $21,056 |
| BON SECOURS SAINT MARYS HOSPITAL OF RICHMOND | Richmond | AstraZeneca | 2012 | Research | $4,000 |
| BURKE INTERNAL MEDICINE INC. STE A. | Burke | AstraZeneca | 2012 | Research | $3,454 |
| CLINICAL RESEARCH INSTITUTE OF NORTHERN VIRGINIA | Burke | AstraZeneca | 2012 | Research | $9,350 |
| EASTERN VIRGINIA MED SCHOOL | Norfolk | AstraZeneca | 2012 | Research | $112,000 |
| DANVILLE ORTHOPEDIC CLINIC | Danville | AstraZeneca | 2012 | Research | $19,647 |
| FAMILY PRACTICE ASSOCIATES | Midlothian | AstraZeneca | 2012 | Research | $10,950 |
| MADAAN, VISHAL | CHARLOTTESVILLE | Forest | 2012 | Research | $1,674 |
| EASTERN VIRGINIA MEDICAL SCHOOL | NORFOLK | Pfizer | 2009 | Research | $26,011 |
| GEORGE WASHINGTON UNIVERSITY | ASHBURN | Pfizer | 2009 | Research | $21,535 |
| VIRGINIA COMMONWEALTH UNIVERSITY | RICHMOND | Pfizer | 2009 | Research | $38,103 |
| EASTERN VIRGINIA MEDICAL SCHOOL | NORFOLK | Pfizer | 2010 | Research | $56,985 |
| GEORGE WASHINGTON UNIVERSITY | ASHBURN | Pfizer | 2010 | Research | $16,625 |
| RECTOR AND VISITORS OF UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE | Pfizer | 2010 | Research | $67,727 |
| THE RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE | Pfizer | 2010 | Research | $7,487 |
| UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE | Pfizer | 2010 | Research | $152,595 |
| VIRGINIA COMMONWEALTH UNIVERSITY | RICHMOND | Pfizer | 2010 | Research | $108,730 |
| EASTERN VIRGINIA MEDICAL SCHOOL | NORFOLK | Pfizer | 2011 | Research | $31,893 |
| EPILEPSY THERAPY PROJECT | MIDDLEBURG | Pfizer | 2011 | Research | $104,000 |
| THE RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE | Pfizer | 2011 | Research | $74,920 |
| UNIV OF VIRGINIA | CHARLOTTESVILLE | Pfizer | 2011 | Research | $73,662 |
| UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE | Pfizer | 2011 | Research | $1,100 |
| VIRGINIA COMMONWEALTH UNIVERSITY | RICHMOND | Pfizer | 2011 | Research | $39,578 |
| EASTERN VIRGINIA MEDICAL SCHOOL | NORFOLK | Pfizer | 2012 | Research | $12,601 |
| UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE | Pfizer | 2012 | Research | $12,430 |
| VIRGINIA COMMONWEALTH UNIVERSITY | RICHMOND | Pfizer | 2012 | Research | $2,469 |
| Aaron B. Pearl | Arlington | Johnson & Johnson | 2011 | Meals | $339 |
| Aaron I Vinik | NORFOLK | Merck | 2010 | Speaking | $30,250 |
| Aaron I Vinik | NORFOLK | Merck | 2011 | Speaking | $22,775 |
| Aaron I Vinik | NORFOLK | Merck | 2009 | Speaking | $20,580 |
| Aaron I Vinik (Payee: EASTERN VIRGINIA MEDICAL SCHOOL CME) | NORFOLK | Merck | 2012 | Research | $25,000 |
| Aaron I Vinik | NORFOLK | Merck | 2012 | Speaking | $6,000 |
| Aaron I Vinik | NORFOLK | Merck | 2012 | Consulting | $7,650 |
| Aaron I Vinik | NORFOLK | Merck | 2012 | Other | $6,852 |
| AARON I VINIK | NORFOLK | Novartis | 2010-11 | Speaking | $4,399 |
| AARON I VINIK | NORFOLK | Pfizer | 2009 | Consulting | $1,000 |
| AARON I VINIK | NORFOLK | Pfizer | 2010 | Consulting | $6,590 |
| AARON I VINIK | NORFOLK | Pfizer | 2010 | Travel | $4,098 |
| AARON I VINIK (Payee: EASTERN VIRGINIA MEDICAL SCHOOL) | NORFOLK | Pfizer | 2011 | Research | $182,604 |
| AARON I VINIK | NORFOLK | Pfizer | 2011 | Consulting | $10,219 |
| AARON I VINIK | NORFOLK | Pfizer | 2011 | Travel | $5,801 |
| AARON I VINIK (Payee: EASTERN VIRGINIA MEDICAL SCHOOL) | NORFOLK | Pfizer | 2012 | Research | $14,894 |
| AARON I VINIK (Payee: EASTERN VIRGINIA MEDICAL SCHOOL) | NORFOLK | Pfizer | 2012 | Research | $109,072 |
| AARON I VINIK | NORFOLK | Pfizer | 2012 | Consulting | $845 |
| AARON I VINIK | NORFOLK | Pfizer | 2012 | Travel | $3,201 |
| Aaron I. Vinik | Norfolk | AstraZeneca | 2011 | Speaking | $3,500 |
| AARON I. VINIK | NORFOLK | Eli Lilly | 2009 | Consulting | $6,438 |
Source
ProPublica research, based on pharmaceutical company disclosures.
Notes
- Some records include both the practitioner listed by the company and the entity receiving payment. If only one name is listed, it represents both the listed practitioner and payee. For instance, some payments made to a university research lab will list the university as the entity receiving payment, and an individual researcher as the practitioner.
- Companies are continually updating their data, so the most recent additions may not be included in our database.
- A physician on the list may be getting money from other companies that have yet to disclose payments.
- Practitioner names and addresses (city/state) are listed as the companies released them and may vary. For instance, some companies include a middle initial, and others do not. Some companies also list different cities for the same individual. This may happen because professionals may have practices in multiple locations or because they provided different addresses for payment.